InvestorsObserver
×
News Home

Do Analysts Expect Kaleido Biosciences Inc (KLDO) Stock to Rise After It Has Fallen -14.68% in a Month?

Wednesday, March 31, 2021 02:46 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Kaleido Biosciences Inc (KLDO) Stock to Rise After It Has Fallen -14.68% in a Month?

Analysts who follow Kaleido Biosciences Inc (KLDO) on average expect it to add 76.82% over the next twelve months. Those same analysts give the stock an average rating of Buy.

That average rating earns KLDO an Analyst Ranking of 29, which means it ranks higher than 29 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.8
Wall Street analysts are rating KLDO a Buy today. Find out what this means to you and get the rest of the rankings on KLDO!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.

InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Kaleido Biosciences Inc Stock Today?

Kaleido Biosciences Inc (KLDO) stock is trading at $8.37 as of 2:42 PM on Wednesday, Mar 31, a rise of $1.11, or 15.29% from the previous closing price of $7.26. The stock has traded between $7.28 and $8.38 so far today. Volume today is less active than usual. So far 134,724 shares have traded compared to average volume of 250,761 shares.

Click Here to get the full report on Kaleido Biosciences Inc (KLDO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App